Discover 2,591 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Illinois offers various clinical research options, including those for healthy volunteers interested in paid studies, as well as for individuals with specific health conditions. Leading research centers in Chicago, Plainfield, and Springfield are actively seeking participants, providing access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 2,591
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Comparing Intravitreal Injection Pain Scores Using Iheezo (Chloroprocaine Hcl Ophthalmic Gel 3%) Versus Subconjunctival Lidocaine (2%): A Randomized, Controlled Trial
for
No Condition
Location: Glen Carbon IL, St Louis MO, Chesterfield MO,
Sponsor: Retina Research Institute, LLC
Sex: All
Age: 18+
Code: NCT07895420
Phase 4, Recruiting
Active & ResponsiveNew
Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease
for
Thyroid Eye Disease (TED), Graves' Disease,
Location: Wilmington NC, Orland Park IL
Sponsor: Ethyreal Bio, Inc.
Sex: All
Age: 18+
Code: NCT07885605
Phase 1, Recruiting
Active & ResponsiveNew
A Study to Determine the Effect of Access to Multiple Tobacco Flavor Options on Smoking Abstinence Among Primary Cigarette Smokers Using an Electronic Nicotine Delivery System
for
Smoking, Tobacco
Location: Iselin NJ, Fort Lauderdale FL, Atlanta GA, Chicago IL,
Sponsor: RAI Services Company
Sex: All
Age: 21 - 65
Code: NCT07879638
Recruiting
Active & Responsive
Home-based FES Training in People With Chronic Stroke
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer,
Location: New Haven CT, Lake Success NY, New York NY, Fairfax VA,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07361562
Phase 1, Recruiting
Active & Responsive
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
for
Metastatic Hepatocellular Carcinoma,
Location: New York NY, Pittsburgh PA, Birmingham AL, Nashville TN,